American Heart Association

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, American Heart Association sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials 4 currently recruiting 5 completed early-phase tilt top decile by trial count

American Heart Association: 9 sponsored US clinical trials, 4 recruiting.

American Heart Association sponsors 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 5 completed. 1 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Atrial Flutter, with 1 trials.

Top-decile sponsor footprint

American Heart Association ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

What is open in the American Heart Association pipeline

4 recruiting of 9 indexed (44% open); 5 completed (56%).

Phase mix: 1 late (III/IV) vs 3 early (I/II) (early-phase heavy).

Top condition: Atrial Flutter (1 trial), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

American Heart Association: open-pipeline peers nationwide

Peers matched on 9 registered trials and 44% open enrollment, not the therapeutic-area sidebar.

American Heart Association sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 51015202530 0%10%20%30%40%50% Total trials Recruiting share American Heart Association4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi companyAscendis Pharma A/SCullinan TherapeuticsMarquette UniversityPalvella Therapeutics
American Heart Association sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

American Heart Association sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 trials (± recruiting share)

Sponsors near 44% open enrollment (± trial volume)

What to do with this American Heart Association page

9 registered trials is a research-attention snapshot, not an endorsement of American Heart Association or any single study.

  • 4 of American Heart Association's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Atrial Flutter is the condition American Heart Association studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Atrial Flutter trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

American Heart Association pipeline card: 9 registered trials from official public datasets.Report a data error.